Profile Picture
Rewards
  • All
  • Images
  • Videos
  • Maps
  • News
  • Shopping
  • More
    • Flights
    • Travel
    • Hotels
  • Top stories
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Politics
  • Business

Trending on Bing

Throat cancer battle
'People are dying’
Perform ‘Karma’ live
US 'won't tolerate'
A green Grand Canal
George Maharis dies
Broke voting record
NK infant jailed
Wins Indy 500
1st show in 20 years
Coca-Cola 600 delayed
Marta Kostyuk booed
Martins narrow escape
Rico in intensive care
First domestic plane
Defends debt deal
Commencement speech
Ceasefire deal
Release debt deal text
Tribal militants dead
Families seek justice
Pentecost celebration
US lawyer uses ChatGPT
Lukashenko in hospital
Oman's Sultan in Iran
Tourist boat overturns
Escaped inmate dead
Swims to the top
Wins Giro d'Italia
Atl. teen shot, dead
Celebrity extravaganza
Wins LIV Golf DC event
Returns from lymphoma
96-yr-old sets record
Iran sanctions bill
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days
  • Best match
    • Most recent
19,300 results
5don MSN
FDA approves prescription nasal spray to reverse opioid overdoses
The Food and Drug Administration (FDA) approved a prescription nasal spray this week that can reverse opioid overdoses. Opvee ...
WTVF26d
FDA approves first over-the-counter naloxone nasal spray
NASHVILLE, Tenn. (WTVF) — The FDA recently approved an over-the-counter naloxone nasal spray. The medication, known as Narcan, reverses the effects of an opioid overdose. Advocates say it's a ...
drugdeliverybusiness5d
FDA approves another nasal spray for treating opioid overdose
The FDA approved Opvee nalmefene hydrochloride nasal spray for the emergency treatment of opioid overdoses from Opiant ...
Seeking Alpha18d
Emergent BioSolutions: A Turnaround In Sight With OTC Narcan Amidst Ongoing Opioid Crisis
The FDA has approved Emergent's over-the-counter Narcan, a drug to treat opioid overdoses. OTC Narcan can contribute significantly to combatting the escalating opioid crisis in the U.S. The OTC ...
Medscape3d
FDA Approvals
FDA Approves Methylphenidate Patch for Teens With ADHD The FDA has approved an expanded age range for a methylphenidate transdermal system for the treatment of ADHD in adolescents aged 13 to 17 years.
ABC News15d
FDA approves first-of-its-kind drug to treat hot flashes
According to the FDA, the drug works by targeting the brain's temperature control center to decrease both the frequency and intensity of hot flashes in women. Prior to the FDA's approval of ...
Riverfront Times23d
St. Louis Man Made a Narcan Dispenser. He Hopes You Do, Too
He hopes other people will be inspired to set up boxes in their own neighborhoods. Related FDA Approves Narcan for Over-the-Counter Use: The medication, which rapidly reverses overdoses ...
5d
FDA Approves New Nasal Spray to Reverse Opioid Overdoses
It’s not yet clear how the drug will be used differently than naloxone, and some experts see downsides to its longer-acting ...
FOX 10 Phoenix
5d
FDA approves new nasal spray to reverse fentanyl, other opioid overdoses
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
EMS1
5d
FDA approves new nasal spray to reverse fentanyl, opioid overdoses
U.S. health regulators on Monday approved a new easy-to-use version of a medication to reverse overdoses caused by fentanyl ...
Too Old to Operate
4d
FDA Approves New Nasal Spray to Reverse Overdoses
The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as Opvee, the spray contains the medication nalmefene hydrochloride and will ...
High Times
4d
FDA Approves Nasal Spray To Reverse Fentanyl Overdoses
The Food and Drug Administration on Monday said that it had given regulatory approval to a nasal spray that has proven ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

Related topics

opioid overdose
Opvee
Food and Drug Administration
© 2023 Microsoft
  • Privacy and Cookies
  • Legal
  • Advertise
  • About our ads
  • Help
  • Feedback